Comparison
GOAL.MD vs Hims
Independent, side-by-side. Same methodology, same sourcing standard, no payment accepted from either. Prices are observed market pricing (snapshot 2026-07-20); receipts are computed from sourced records.
| GOAL.MD | Hims | |
|---|---|---|
| Verdict | Profile in progress | Profile in progress |
| Tirzepatide price | from $397/mo (monthly plan) | Not tracked |
| Semaglutide price | from $397/mo (monthly plan) | from $199/mo (12-mo prepay) |
| Pharmacy receipt | Fills through Red Rock per market data (not the clinic's own disclosure). Pick your state to check licenses. | Names its pharmacy (Strive Pharmacy, Curexa +1) — Strive Pharmacy, RedRock Pharmacy state-verified by us in up to 17 states. Pick your state to check yours. |
| Care receipt | Clinician model in review; check-ins and coaching on record. | Care is outsourced to You Health — a contract medical group named on the clinic's own site. The brand doesn't employ your clinician. |
| Review integrity | Clean review record — 22% unprompted on 77 reviews, within our 40% threshold. | Review-integrity flag — 72% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold. |
| Company address | A real-looking operating address is on the public record, but the company does not publish it on its own pages. | Its listed address is a registered-agent or mailbox service — no operating location stands behind the brand's listed address. |
| Pharmacy | In review | In review |
| Clinical support | In review | In review |
| Patient support | In review | In review |
| Value | In review | In review |
| Ships to | In review | In review |
| Pharmacy model | GOAL.MD does not name its compounding pharmacy partners anywhere located as of the access date (homepage, GLP-1 treatment pages, Terms & Conditions, and billing pages were all reviewed). Its pages state only that compounded medications are 'personalized formulations prepared by licensed U.S. 503A or 503B compounding pharmacies' and reference 'independent licensed pharmacy partners' generically, with a 'Compounded in USA' footer note. For its separate Brand-Name Access program, fulfillment is not via a compounding pharmacy at all: Ozempic and Wegovy route through NovoCare/TrumpRx coupons redeemed at a local pharmacy, and Zepbound (vial and KwikPen) routes through LillyDirect with home delivery or Walmart pickup. | Hims is unusually vertically integrated for a GLP-1 telehealth brand: Hims & Hers Health, Inc. owns and operates its own pharmacy and manufacturing chain rather than only contracting out. Per its FY2025 Form 10-K, the company operates two licensed 503A mail-order pharmacies that fill solely for its own customers - Apostrophe Pharmacy LLC and XeCare, LLC, both now wholly-owned subsidiaries - plus a licensed 503B outsourcing facility, MedisourceRx (acquired September 2024 as Seaview Enterprises, LLC, for $31.0 million; Los Alamitos, CA), which compounded its injectable semaglutide, and a peptide manufacturing facility. The consumer Terms also name third-party partner pharmacies (EHT Pharmacy LLC dba Curexa, CD Pharmacy LLC dba Red Rock Pharmacy, AnazaoHealth Corporation, and Strive Specialties, Inc.). During the April-June 2025 Novo Nordisk bundle, brand-name Wegovy was dispensed through Novo's own NovoCare Pharmacy accessed via the Hims platform. Prescriptions are written by providers in affiliated 'You Health' professional medical groups; Hims & Hers states in its Terms that it is not itself a healthcare provider. |
| Red flags on file | 4 | 5 |
Visit goal.md
Plain link, not sponsored — we take no payment for this.
Visit hims.com
Plain link, not sponsored — we take no payment for this.
Full profiles: GOAL.MD → · Hims →
State-aware license reads: the tirzepatide price board →